# Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting Conditions

> **NCT02138396** · NA · COMPLETED · sponsor: **INSYS Therapeutics Inc** · enrollment: 12 (actual)

## Conditions studied

- Bioavailability

## Interventions

- **DRUG:** Fentanyl Sublingual Spray (FSS)
- **DRUG:** Fentanyl Citrate Injection (FCI)
- **DRUG:** Naltrexone

## Key facts

- **NCT ID:** NCT02138396
- **Lead sponsor:** INSYS Therapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02138396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02138396, "Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting Conditions". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02138396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*